| LDR | 02213nam a22003131a 4500 | ||
| 001 | 000187774 | ||
| 003 | MiAaHDL | ||
| 005 | 20210817000000.0 | ||
| 006 | m d | ||
| 007 | cr bn ---auaua | ||
| 008 | 880715s1981 nyua b 00000 eng | ||
| 010 | ⊔ | ⊔ | ‡a80005371 |
| 020 | ⊔ | ⊔ | ‡a0890045348 |
| 035 | ⊔ | ⊔ | ‡a(MiU)990001877740106381 |
| 035 | ⊔ | ⊔ | ‡asdr-miu.990001877740106381 |
| 035 | ⊔ | ⊔ | ‡a(OCoLC)7553512 |
| 035 | ⊔ | ⊔ | ‡a(CaOTULAS)160276993 |
| 035 | ⊔ | ⊔ | ‡a(RLIN)MIUG82-B47526 |
| 035 | ⊔ | ⊔ | ‡z(MiU)Aleph000187774 |
| 040 | ⊔ | ⊔ | ‡dMiU |
| 050 | 0 | ⊔ | ‡aRM332 ‡b.A58 |
| 060 | ⊔ | ⊔ | ‡aQV 77.5 A629 |
| 082 | 0 | ⊔ | ‡a615/.788 ‡219 |
| 245 | 0 | 0 | ‡aAntidepressants : ‡bneurochemical, behavioral, and clinical perspectives / ‡ceditors, S.J. Enna, Jeffrey B. Malick, Elliott Richelson. |
| 260 | ⊔ | ⊔ | ‡aNew York : ‡bRaven Press, ‡cc1981. |
| 300 | ⊔ | ⊔ | ‡ax, 261 p. : ‡bill. ; ‡c24 cm. |
| 504 | ⊔ | ⊔ | ‡aIncludes bibliographies and index. |
| 505 | 0 | ⊔ | ‡aRamsey and Joe Mendels -- Plasma levels of tricyclic antidepressants and clinical efficacy / S. Craig Risch, David S. Janowsky, and Leighton Y. Huey -- An overview of new "second generation" antidepressant compounds / B. Shopsin, G.B. Cassano, and L. Conti. |
| 505 | 0 | ⊔ | ‡aEnhancement of monoaminergic neurotransmission by antidepressant drugs / Ray W. Fuller -- Chronic antidepressant administration and adaptive changes in central monoaminergic systems / Michael F. Sugrue -- Down-regulation of the central noradrenergic receptor system by antidepressant therapies / Philip L. Mobley and Fridolin Sulser -- Tricyclic antidepressants / Elliott Richelson -- Interactions of antidepressants with neurotransmitter receptor sites / Stephen J. Peroutka and Solomon H. Snyder -- Effect of chronic antidepressant administration on brain neurotransmitter receptor binding / S.J. Enna ... [et al.] -- Empirical behavioral models of depression, with emphasis on tetrabenazine antagonism / James L. Howard, Francis E. Soroko, and Barrett R. Cooper -- Behavioral despair / R.D. Porsolt -- Yohimbine potentiation as a predictor of antidepressant action / Jeffrey B. Malick -- Neurophysiologic techniques and antidepressive activity / Ronald G. Babington -- Lithium ion as an antidepressant / T. Alan |
| 538 | ⊔ | ⊔ | ‡aMode of access: Internet. |
| 650 | ⊔ | 0 | ‡aAntidepressants |
| 700 | 1 | ⊔ | ‡aRichelson, Elliott. |
| 700 | 1 | ⊔ | ‡aMalick, Jeffrey B. |
| 700 | 1 | ⊔ | ‡aEnna, S. J. |
| CID | ⊔ | ⊔ | ‡a000187774 |
| DAT | 0 | ⊔ | ‡a19880715000000.0 ‡b20210817000000.0 |
| DAT | 1 | ⊔ | ‡a20210925140719.0 ‡b2024-02-27T18:32:05Z |
| DAT | 2 | ⊔ | ‡a2024-02-27T18:30:02Z |
| CAT | ⊔ | ⊔ | ‡aSDR-MIU ‡dALMA ‡lprepare.pl-004-008 |
| FMT | ⊔ | ⊔ | ‡aBK |
| HOL | ⊔ | ⊔ | ‡0sdr-miu.990001877740106381 ‡aMiU ‡bSDR ‡cMIU ‡pmdp.39015000283203 ‡sMIU ‡1990001877740106381 |
| 974 | ⊔ | ⊔ | ‡bMIU ‡cMIU ‡d20240227 ‡sgoogle ‡umdp.39015000283203 ‡y1981 ‡ric ‡qbib ‡tUS bib date1 >= 1929 |